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Absence of serological response in CF-paSents colonized with 
Pseudomonas aeruginosa 
G.A. Trampe rl, T.F.W. Wolfs 2, C.K. van der Ent 1 
iCF-center Utrecht, 2Dep. of pediatric infectious diseases, Univemity Medical 
Center Utrecht, The Netherlands 
Aims: Aggressive treatment of early Pseudomonas aeruginosa (PA) infection may 
prevent persistent colonization. Therefore, detection of PA is of major relevance. 
Both culture and serological methods are used to detect PA. Our objective was to 
re assess the value of serology in a large and diverse CF population. 
Methods: At our CF center, we studied cultures and serology of 172 pediatric (mean 
age 9.90 y) and 48 adult (mean age 30.75 y) patients. Sputum and oropharyngeal 
cultures taken in 2CO2 2CO4 were analyzed. We categorized patients as follows: 
chronic PA colonization (>50% of all cultures positive), intermittent PA 
colonization mad negative (no positive culture). Commercially available 
semiquantitative IgG ELISA against 3 antigens (elastase, alkaline protease, 
exot oxin A) was performed on serums collected in 2CO4. A titer of >1:500 against 
one or more PA antigens was considered positive. 
Results: We found chronic PA colonization ha 42 (24%) pediatric and 25 (52%) 
adult patients. Sensitivity of combined antibodies for chronic colonization was 
79%. Sensitivity of the individual antibody elastase was 60 %, exot oxin A 51% mad 
alkaline protease 54%. Negative serology occurred ha 8 pediatric and 6 adult 
patients with chronic PA colonization. Sensitivity of combined antibodies for 
intermittent colonization was 33% (elastase 19%, exot oxin A 26%, alkaline pr otease 
19%). Based on culture and serology, 73 children (42%) mad 10 adults (21%) did 
not have evidence of PA infection during study period. 
Conclusions: Chronically infected patients do not tmiformly show an antibody 
response. Combining multiple antigens increases ensitivity of serology. Further 
investigation is needed for host and bacterial related factors that affect antibody 
response. 
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Vaccine failure in CF 
A. Malfroot 1, E. De Wachter 1, D. Pier ard 2, S. Lauwer s2 
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The prevention of hlfluenza by vaccination represents an essential task for 
physicians caring for CF patients. However, because vaccines are currently not 
approved for children < 6 months of age, and the majority are poorly immunogenic 
in young children in general, vaccination is often postponed until older ages. Even 
the adult CF patients have not been systematically studied to determine whether 
they make a normal response to all vaccines and the possibility of vaccine failure is 
still an unanswered issue, as reported in patients with chronic liver and renal 
disease. Methods: A total of 109 pediatric and adult patients were vaccinated 
against influenza in our center, during winter 2CO3 2CO4. Results: 2 patients 
showed documented vaccine failure: a 15 yrs old male and a 27 yrs old female. 
Influenza A CF antibody raised to 160 after vaccination, decreased again, then rose 
to 640 during high fever and viral symptoms 2 months after vaccination. The oldest 
patient showed rapid pulmonary decline and died 3 months later, 3 weeks after lung 
transplantation. Discussion: To our knowledge it is never studied it" CF patients 
respond normally to all the vaccines mad risk of vaccine failure is not documented 
in CF. It could be that response is reduced ue to the high level of IgG in CF, also 
for some other vaccines. On the other hand it was never described that vaccine 
preventable infections are more prevalent in CF. 
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Specific vaccination protects mice from lung infection with 
serospecific Pseudomonas aeruginosa 
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Pseudomonas aeruginosa is an oppor ttmistic pathogen, which is correlated closely 
with cbr onic lung infection in Cystic Fibrosis patients. Such infection is difficult to 
eradicate despite intensive antibiotic treatment. Therefore, prevention of /~ 
aeruginosa infection by vaccination is timely desirable. 
A im of the study: A specific conjugated vaccine of immunotype (IT) 4 of 
Lipopolysaccharide (LFS) and toxin A (TA) was tested for its protective ffect on 
mice suffering from chronic lung infection caused by set ospecific/~ aeruginosa 53. 
Materials & Methods: I. Vaccine group (VG): IT 4+TA (2 ~tg/mouse) and Cholera 
Toxin (0.2 ~tg/mouse), control group (CG): sterile saline. II. Mice were vaccinated 
twice on day 28 & day 14 respectively, challenged on day 0, and sacrificed on day 
5 after infection. III. Mortality, lung bacteriology, and lung pathology were 
evaluated after challenge. Serum immtmoglobulin (Ig) G antibodies against ITs4 
and TA were measured on day 28, day 0, and day 5, respectively. 
Results: The mortality rates were 43.75% in the VG and 75.76% in the CG, the 
differences were significant (p<0.01). Semm IgG against IT4  and TA ha the VG 
significantly increased on day 0 (p<0.01 for IgG4T4; p<0.05 for IgG TA) mad day 
5 (p<0.001 for IgG4T4; p<0.03 for IgG TA) compared to CG However, no 
significant difference was found in macroscopic lung pathology mad lung 
bacteriology ha both groups. 
Conclusion: Specific vaccination with IT 4+TA conjugate significantly induces the 
production of IgG against IT4  and TA in mice, and simultaneously protects mice 
from lethal ung infection with the serospecific/~ aeruginosa 53 strain. 
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Control and prevention of infections in cystic fibrosis patients: 
literature review 
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We have conducted a review of the scientific literature on the following aspects 
pertaining to the prevention and control of infections due to classic pathogens: 
causal relationship between infection and prognosis 
transmission of germs 
risk factors for acquiring infection 
• efficacy of hygienic practices in the prevention of infection 
The content of the 7 most important Guidelines were compared. Over 4120 papers 
were selected from Medline, Embase, CINHAL and the Ccchrane Library, 
including systematic and narrative reviews, randomized and controlled trials (RCT), 
relevant observational studies, and congress prcceedings up to December 2CO4. Our 
analysis shows that recommendations of the principal international guidelines and 
in general, the acquired knowledge in this field is based on observational studies, 
consensus and expert opinion rather than on RCT. On the basis of the examined 
studies, acquisition ofP. aeruginosa (Pa) is associated with increas~l morbidity and 
mortality mad decreased FEV1. B. cepacia complex (Bcc) further compromises 
FEV1 and survival. There are no demonstrable infuences on proguosis regarding 
MRSA, A. xylosoxidans, S. malt ophilia and NT mycobacteria. The lransmissibility 
of MRSA and non fermentative Gram negative bacteria has been documented. 
Patient cohor ting seems to be efficacious in preventing transmission of Bee and Pa, 
as does reduction of interpersonal contact outside hospitals mad adequate hand 
hygiene in reducing risk of transmission. 
Risk factors for acquisition of germs include external environmental f ctors such as 
sharing of respiratory devices and spaces for prolonged periods, cohabitation, 
summer camps, participation in educational programs, travel by car, and fitness 
courses. 
The final synthesis of the article is a finalized report of the revision of the guidelines 
for infection control in Italian CF Centers mad for the daily lit~ of patients. 
